|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-8-1
|
|
pubmed:abstractText |
There is increasing interest in identifying a blood-based marker for the asbestos-related tumor, malignant mesothelioma. Three potential markers for mesothelioma are mesothelin, megakaryocyte potentiating factor (MPF) and osteopontin. The purpose of the current study was to directly compare these biomarkers in the same sample population, determining their sensitivity and specificity in establishing a diagnosis, and to determine if diagnostic accuracy for mesothelioma is improved by combining the data from all three markers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
851-7
|
|
pubmed:dateRevised |
2011-10-26
|
|
pubmed:meshHeading |
pubmed-meshheading:18670302-Adult,
pubmed-meshheading:18670302-Aged,
pubmed-meshheading:18670302-Aged, 80 and over,
pubmed-meshheading:18670302-Antigens, Neoplasm,
pubmed-meshheading:18670302-Female,
pubmed-meshheading:18670302-GPI-Linked Proteins,
pubmed-meshheading:18670302-Humans,
pubmed-meshheading:18670302-Male,
pubmed-meshheading:18670302-Membrane Glycoproteins,
pubmed-meshheading:18670302-Mesothelioma,
pubmed-meshheading:18670302-Middle Aged,
pubmed-meshheading:18670302-Osteopontin,
pubmed-meshheading:18670302-Pleural Neoplasms,
pubmed-meshheading:18670302-Prognosis,
pubmed-meshheading:18670302-ROC Curve,
pubmed-meshheading:18670302-Sensitivity and Specificity,
pubmed-meshheading:18670302-Survival Rate,
pubmed-meshheading:18670302-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.
|
|
pubmed:affiliation |
National Research Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Australia. creaneyj@cyllene.uwa.edu.au
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
